P.O. Box 1298 West Chester, PA 19380


NEW YORK, NY – April 30, 2020 – International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, today announced the next edition of INTERPHEX, previously postponed to July 2020, will now take place April 20-22, 2021 at the Javits Center in New York.

“While facing an unprecedented situation, we needed to make tough choices and felt this was the best way to proceed for everyone involved”, said Randy Field, Group Vice President, Reed Exhibitions. “We are grateful for and proud of our customers and the entire industry who supported the event in 2020. Each play a critical role in making INTERPHEX by far the most important gathering for pharmaceutical, bio and device development and manufacturing professionals. While we recognize and appreciate how important INTERPHEX is to the industry, based upon the current COVID-19 situation and in the interest of the safety of all of our customers, we believe it is the right decision to hold INTERPHEX in 2021 when we can ensure the industry is ready and able to get back to business.”

Kate Scott, Event Director, INTERPHEX said, “Our entire team is here to support all of our customers and partners and we are passionate about providing new options for us to come together virtually throughout the summer and with smaller face-to-face interactions opportunities in the fall, when we can.  Stay tuned for more information coming soon.”

INTERPHEX is developing additional channels beyond the show floor to connect pharma, bio and device development and manufacturing professionals with leading suppliers. One such tool is the recently launched, RECONNEX 365, offering access to exhibitor expertise and technical know-how to more easily source for capital and maintenance projects and other essential technical information needed to develop and manufacture quality products. For more information, visit www.interphex.com/RECONNEX-365.

Scott continued, “You will see even more tools, resources and innovative solutions coming from the INTERPHEX team.  These will allow you to make new connections, meet leading suppliers, source technologies, products and services and learn from industry subject matter experts to enable you to find solutions to develop and manufacture cost-effective, quality therapeutics for the global population.”  

For 41 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event to “Experience Science through Commercialization.” Sponsored by the Parenteral Drug Association (PDA), INTERPHEX is a face-to-face event, bringing together attendees and leading suppliers through exhibits, networking, technical conference and digital tools to deliver cost effective solutions to develop and manufacture quality product. INTERPHEX and INNOPHEX, a collocated event focused on cell processing, gene therapy and disruptive technologies, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. For more information, visit www.INTERPHEX.com.

About Reed Exhibitions:
Reed Exhibitions is a leading global events business. It combines face-to-face with data and digital tools to help customers learn about markets, source products and complete transactions at over 500 events in almost 30 countries across 43 industry sectors, attracting more than 7 million participants. Our events, organized by 35 global offices, leverage industry expertise, large data sets and technology to enable our customers to generate billions of dollars of revenues for the economic development of local markets and national economies around the world. Reed Exhibitions is part of RELX, a global provider of information and analytics for professional and business customers across industries. www.reedexhibitions.com.

Leave a comment